Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

Recruiting now

Conditions studied: Sugammadex

In brief

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Key facts

Study ID

NCT05886218

Run by

University of California, Davis

People needed

215

Starts

2023-02-08

Expected to finish

2025-07-01

Last updated by the study team

2025-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age greater than 18 years
• scheduled for an elective laparoscopic gastric bypass procedure

You may not qualify if…

• age less than 18 years
• pregnancy
• prisoners
• significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
• patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2>98%)

Where it is running

• UC Davis Medical Center — Sacramento, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.